Sign In
Neuroendocrine Clinical Trials
Page Introduction
| Protocol No. | PI | Title |
|---|
| OSU-9812 | Albert de la Chapelle | A Strategy to Search for Genes Predisposing to Papillary Carcinoma of the Thyroid When Mutated |
| OSU-05034 | Richard Kloos | Retrospective Clinicopathological Review & Analysis of Benign Thyroid and Thyroid Cancers Cases from the Ohio State University Medical Center to Determine Factors Influencing Diagnosis, Treatment and Long Term Outcome. |
| OSU-06032 | Richard Kloos | The Endocrine Neoplasia Repository (ENR). |
| OSU-11126 | Richard Kloos | Salivary gland damage and dysfunction in patients with differentiated thyroid cancer treated with radioactive iodine. |
| OSU-12154 | Manisha Shah | Phase II Study of Cabozantinib in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on First-Line VEGFR-Targeted Therapy |
| OSU-12153 | Manisha Shah | A multicenter, two stage, phase II study, evaluating the efficacy of oral BEZ235 plus best supportive care (BSC)versus placebo plus BSC in the treatment of patients with advanced pancreatic neuroendocrine tumors (pNET) after
failure of mTOR inhibitor therapy. |
| OSU-07080 | Manisha Shah | A Banking Facility for Biological Samples and Clinical Data to Study Neuroendocrine Tumors |
| OSU-09067 | Manisha Shah | A Phase II Trial of Temsirolimus and Bevacizumab in Patients with Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid or Islet Cell Cancer |
Page Body
Page Closing
© The Ohio State University